Product Information

METRONIDAZOLE 500 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.1012 per EA under NDC 00904712661. Its NADAC has been published 266 times since Jul 21, 2021.

FDA first approved this application on Sep 23, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METRONIDAZOLE 500 MG TABLET

METRONIDAZOLE
$0.1012per EA

Strength

500 mg/1

NDC

00904712661

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

METRONIDAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA205245

FDA Approved

9/23/2015

TE Code

AB

On Market Since

11/29/2017

Pharmacological Classes

Price Statistics

The NADAC for METRONIDAZOLE 500 MG TABLET has been published 266 times since Jul 21, 2021, and over the history we have for it it has declined 33.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1012 per EA
All-time high$0.1572 (Nov 10, 2021)
All-time low$0.0797 (Nov 20, 2024)
52-week high$0.1094
52-week low$0.0999
Median price$0.1256
Average price$0.1231
Largest weekly change+39.1% (Jun 19, 2024)
Weeks tracked266
Tracking sinceJul 21, 2021

Price History

1W

+0.9%

1M

+0.9%

3M

+0.4%

6M

+1.1%

1Y

-7.6%

3Y

-23.9%

5Y

-32.2%

All

-33.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of METRONIDAZOLE 500 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE 500 MG TABLET, manufactured by Major Pharmaceuticals, is $0.1012 per EA (NDC 00904712661), effective Aug 19, 2026.

How has the price of METRONIDAZOLE 500 MG TABLET changed over time?

Over the history we have for it, the NADAC for METRONIDAZOLE 500 MG TABLET has declined 33.8%. It has been tracked across 266 weekly CMS publications since Jul 21, 2021.

What are the highest and lowest recorded NADAC prices for METRONIDAZOLE 500 MG TABLET?

Since Jul 21, 2021, the NADAC for METRONIDAZOLE 500 MG TABLET has ranged from a low of $0.0797 (Nov 20, 2024) to a high of $0.1572 (Nov 10, 2021), with a median of $0.1256 per EA.

Are there cheaper alternatives to METRONIDAZOLE 500 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as METRONIDAZOLE 500 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures METRONIDAZOLE 500 MG TABLET?

METRONIDAZOLE 500 MG TABLET (NDC 00904712661) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.